Tracking and Treating Uveitic Macular Edema: A Difficult Dilemma

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Bausch + Lomb.

Activity Description

Uveitic macular edema (UME) has a wide variety of causes. If not appropriately treated, it eventually causes damage to the photoreceptors in the macula, resulting in vision-threatening complications like macular ischemia or macular hole formation. Corticosteroids are the first-line treatment for uveitic inflammation and UME. However, they are not generally considered to be appropriate for long-term treatment due to adverse effects, including increased intraocular pressure and cataract in local therapy, as well as osteonecrosis and adrenal insufficiency with systemic treatment. Although, the development of sustained-release delivery systems may reduce the risk of adverse events. In this educational activity, expert clinicians will assess recent evidence regarding the use of multimodal imaging and biomarkers that aid in the detection and monitoring of UME and evaluate recent clinical data about the use of emerging and approved novel corticosteroid delivery systems in the treatment of UME.

Target Audience

The intended audience for this activity is retina specialists and other healthcare professionals involved in the management of patients with uveitic macular edema (UME).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Assess recent evidence regarding the use of multimodal imaging and biomarkers that aid in the detection and monitoring of uveitic macular edema (UME).
• Appraise new evidence about the use of novel corticosteroid delivery systems in the treatment of UME.

Activity Chair

Sunil K. Srivastava, MD
Staff Physician
Director of Vitreoretinal Fellowship Programs
Cole Eye Institute
Cleveland Clinic
Cleveland, OH

Faculty

Sumit Sharma, MD
Cole Eye Institute
Cleveland Clinic
Cleveland, OH

Medical Writer

Valerie Zimmerman, PhD

The articles in this monograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Sharma and Srivastava during a satellite symposium held on January 18, 2023. The monograph has been approved by each of the faculty individually as an accurate representation of their presentations.

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, April 28, 2023, to April 27, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Sumit Sharma, MD
Consultant: AbbVie, Alimera, Allergan, Apellis, Bausch + Lomb, Clearside, EyePoint

Sunil K. Srivastava, MD
Consultant: Bausch + Lomb, EyePoint, Eyevensys, Zeiss
Independent Research Contractor: Eyevensys

Medical Writer reports the following relevant financial relationship(s)

Valerie Zimmerman, PhD
No relevant financial relationships to disclose.

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com